19 Jun, 2013
The Leela Palace, Bengaluru
Home >> Private Equity >>
Friday, June 15, 2012 - 16:05 IST
Thyrocare promoters seek to divest stake to fund new venture 
BY Shrija Agrawal
The promoters are looking to dilute at a huge mark-up to the last round of funding.
The promoters of Thyrocare, country's largest thyroid testing laboratory chain, are looking to dilute up to 10 per cent stake in the company to finance the growth plans of its new arm, a top executive of the firm...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 23 May 2013Murali ApparajuonInteresting surmises! What makes the takeaways less validated however is the lack of disclosure or at least a...
- 23 May 2013VaradhaonPhoenix LP's are managing your money and my money - so they ought to maintain an arm's length and review...
- 21 May 2013PhoenixonWell said Varadha. This comment of your is unclear, " LPs ought to maintain an arm's distance from GPs and...
- 21 May 2013AnooponThe biggest problem in Indian PE fund GPs is Ethics. They want Day-One-Carry rather than long term carry. There should...
UPCOMING EVENTSchinetwork